AcouSort AB (SE:ACOU)

:ACOU

ACOU

AcouSort AB

RESEARCH TOOLSreports

Want to see SE:ACOU full AI Analyst Report?

AcouSort AB (ACOU) Price & Analysis

0 Followers

ACOU Stock Chart & Stats

kr2.64

-kr3.18(-45.56%)

At close: Mar 06 4:00 PM EST

kr2.64

-kr3.18(-45.56%)

Day’s Range― - ―

52-Week Rangekr2.03 - kr4.48

Previous CloseN/A

Volume449.84K

Average Volume (3M)29.24K

Market Cap

kr85.71M

Enterprise Valuekr79.42M

Total Cash (Recent Filing)kr6.29M

Total Debt (Recent Filing)kr0.00

Price to Earnings (P/E)―

Beta0.28

Next Earnings

May 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.12

Shares Outstanding21,163,902

10 Day Avg. Volume27,764

30 Day Avg. Volume29,240

Financial Highlights & Ratios

PEG Ratio0.12

Price to Book (P/B)3.27

Price to Sales (P/S)7.79

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.4

Revenue Forecast (FY)kr18.80M

Bulls Say, Bears Say

Bulls Say

Debt-free Balance SheetHaving zero reported debt materially reduces refinancing and interest-rate risk and preserves optionality for capital allocation. For a cash-burning biotech, a debt-free structure gives management flexibility to raise equity or partner strategically without near-term debt servicing constraints.

Improving Top-line MomentumA 22% revenue increase in 2025 after a weaker prior year signals improving commercial traction and customer adoption of the product platform. Sustained revenue growth can enable operating leverage and increase the odds that R&D and fixed costs can be absorbed over the medium term.

Proprietary Acoustofluidic PlatformA differentiated acoustic wave–based sorting and sample prep technology addresses structural growth areas (cell therapy manufacturing, diagnostics, research). Embedded module sales to instrument OEMs can create durable, sticky revenue streams if integrated into customer workflows and validated at scale.

Bears Say

Persistent Losses & Weak MarginsConsecutive annual losses and negative operating margins show the current business model lacks profitable unit economics. Without sustained margin improvement or structural cost reductions, profitability is unlikely within months, increasing operating risk and the need for external capital over the medium term.

Poor Cash GenerationRepeated negative operating and free cash flows indicate the core business is not self-funding and raises financing and dilution risk. Continued cash burn constrains investments in commercialization and product development unless offset by durable revenue scaling or external financing.

Small Scale And Funding DependenceA very small workforce and variable equity infusions point to limited internal capacity to commercialize broadly and a reliance on external funding. This increases execution risk: scaling sales, manufacturing, and regulatory support may require capital and time that current resources struggle to provide.

ACOU FAQ

What was AcouSort AB’s price range in the past 12 months?

AcouSort AB lowest stock price was kr2.03 and its highest was kr4.48 in the past 12 months.

What is AcouSort AB’s market cap?

AcouSort AB’s market cap is kr85.71M.

When is AcouSort AB’s upcoming earnings report date?

AcouSort AB’s upcoming earnings report date is May 27, 2026 which is in 26 days.

How were AcouSort AB’s earnings last quarter?

AcouSort AB released its earnings results on Feb 25, 2026. The company reported -kr0.12 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.12.

Is AcouSort AB overvalued?

According to Wall Street analysts AcouSort AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does AcouSort AB pay dividends?

AcouSort AB does not currently pay dividends.

What is AcouSort AB’s EPS estimate?

AcouSort AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does AcouSort AB have?

AcouSort AB has 21,163,902 shares outstanding.

What happened to AcouSort AB’s price movement after its last earnings report?

AcouSort AB reported an EPS of -kr0.12 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.775%.

Which hedge fund is a major shareholder of AcouSort AB?

Currently, no hedge funds are holding shares in SE:ACOU

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

AcouSort AB

AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company was founded in 2010 and is based in Lund, Sweden.